OQS
VRCA icon

Occudo Quantitative Strategies’s Verrica Pharmaceuticals VRCA Stock Holding History

Occudo Quantitative Strategies’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,248
Closed -$81.1K – 1313
2023
Q1 		$81.1K Buy
+1,248
New +$75.5K 0.01% 832
2022
Q4 		– Sell
-1,776
Closed -$52K – 1404
2022
Q3 		$52K Sell
1,776
-2,093
-54% -$71.7K ﹤0.01% 1088
2022
Q2 		$74K Buy
+3,869
New +$194K 0.01% 1042

Other funds holding VRCA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Occudo Quantitative Strategies's VRCA Position: Q2 2023 in Review

Occudo Quantitative Strategies sold out of Verrica Pharmaceuticals (VRCA) in Q2 2023, closing a stake of 1,248 shares — an estimated $81.1K sold.

Occudo Quantitative Strategies first reported a position in VRCA in Q2 2022 and held it in 3 quarters. The position peaked at $81.1K in Q1 2023. 63 funds tracked by Wall St. Rank hold VRCA as of Q2 2023.

  • Occudo Quantitative Strategies reported no remaining Verrica Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 1,248 Verrica Pharmaceuticals shares in Q2 2023, an estimated $81.1K.
  • Occudo Quantitative Strategies first reported a position in Verrica Pharmaceuticals in Q2 2022 and held it in 3 quarters.
  • Occudo Quantitative Strategies's Verrica Pharmaceuticals position peaked at $81.1K in Q1 2023.
  • 63 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q2 2023.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2023, filed 14 Aug 2023.